glp-1 agonist benefits Cardiovascular of glucagon-like peptide-1 receptor agonists GLP-1 Receptor - Mousai Wellness

Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a randomized clinical trial

GLP-1 = glucagon-like peptide-1

Younger participants (1849 years) exhibited a higher risk of suicidal ideations or attempts (3.01, 95% CI: 2.703.37), while older participants ( 70 years) had a lower overall risk of psychiatric diseases (1.71, 95% CI: 1.611.82)

They were also more likely to achieve clinically meaningful milestones like losing 5% or 10% of their starting weight

Its important to talk to your healthcare provider before making any changes to your diabetes treatment plan

Is Retatrutide a drug or supplement